Feeling in control of food choices, not controlled by medication
Acetyl-l-carnitine deficiency in patients with major depressive disorder Proceedings of the National Academy of Sciences (2018), DOI: 10.1073/pnas.1801609115 10
A comprehensive review of preclinical toxicology in animals with and without diabetes by European and US regulatory authorities found no evidence of incretin-associated pancreatic toxicity
Optimizing Endpoints for GLP-1 RA Clinical Trial Success Empowering Patient-Centric Research in Obesity, Diabetes, and Cardiovascular Health As GLP-1 receptor agonists (GLP-1 RAs) revolutionize the treatment landscape for obesity, diabetes, and related cardiovascular complications, Signant leads the way in capturing critical patient-reported outcomes (PROs) data
Ready to jumpstart your weight loss
Il dimagrimento ottenuto assumendo i farmaci anti-obesit della classe degli agonisti del recettore Glp-1 , come Ozempic e Wegovy, non dura a lungo dopo aver sospeso la terapia : una nuova vasta analisi sui dati emersi da ben 48 studi sugli effetti a medio termine di questi prodotti, ha osservato, tra i pazienti che avevano interrotto il trattamento, una ripresa del 60% dei chili che erano stati eliminati
